BRIEF-Eli Lilly's Covid-19 Antibody Treatment To Be Sold Commercially - WSJ

Aug 3 (Reuters) -

* ELI LILLY’S COVID-19 ANTIBODY TREATMENT TO BE SOLD COMMERCIALLY - WSJ

* BIDEN ADMINISTRATION, ELI LILLY IN TALKS TO ENSURE BEBTELOVIMAB REMAINS AVAILABLE TO PEOPLE WITHOUT HEALTH INSURANCE - WSJ Source text: https://on.wsj.com/3PWpWdO Further company coverage